IRF3 and hepatocellular carcinoma: Mechanistically, this disruption leads to persistent DNA damage, activating the cGAS-STING pathway in both HCC cells and M1 macrophages, which drives PD-L1 expression via STING-IRF3-STAT1 signaling, promoting immunosuppression and tumor progression.